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Genistein is a phytoestrogen belonging to the group of isoflavons with a wide variety of pharmacological effects. Genistein is synthetised in plants from flavanone naringenin. The major dietary source of genistein are soya products (DIXON & FERREIRA 2002) .
There exist numerous data showing the protective effects of soya products in animal models and in epidemiological studies (ROSENBERG ZAND et al. 2002) . A cross-national study involving 50 countries identified soya products as foods with a protective effect against prostate cancer (HERBERT et al. 1998) . The low incidence of breast cancer in Asian women compared to women in western countries was attributed to a high consumption of soya products (ADLERCREUTZ et al. 1991; LEE et al. 1991) . This correlation is less evident among the second generations of Asian immigrants to USA adopting a western style diet (ZIEGLER et al. 1993) . Urinary levels of soya derived isoflavones (ZHENG et al. 1999 ). An association between high soya intake and lower incidence of endometrium cancer were also described (GOODMAN et al. 1997) . Epidemiologic data are summarised in PARK and SURH (2004) . In a study of LAMARTINIERE et al. (2002) , genistein was confirmed as an agent protecting animals against experimentally induced mammary and prostate cancers. The antiestrogenic activity of genistein is the probable mechanism of its chemopreventive effect. Genistein shares the structural similarity with estrogen estradiol 17 β and the ability to be tied up with estrogen receptors. Thus, genistein exerts both estrogenic and antiestrogenic activities, the latter one by competing for estradiol receptors. The opposite effects are attributed to different responses provoked by different doses of genistein, which in lower concentrations exerts estrogen-like activity, in higher concentrations may act as an antiestrogen and an inhibitor of the tumour-promoting effects of estrogens (SARKAR & LI 2002 .
Antimutagenic Effect of Genistein
Genistein has been shown to be an inhibitor of several intracellular enzymes such as tyrosin kinases, topoisomerase II, phosphatidylinositol kinases, ABC transporters, where genistein ligates their ATP-binding domain, thus involving cell signalling cascades and cell cycle progression. These effects on the molecular and cellular levels are summarised in POLKOWSKI and MAZUREK (2000) ; LI (2002, 2004) ; PARK and SURH (2004) . On the cellular level, it induces cellular differentiation, alters cell cycle progression, inhibits cell proliferation, and induces apoptosis. Genistein has an antiangiogenic effect, inhibits proteins involved in the multidrug resistance of cancer cells. Genistein exerts an antioxidant effect, protects cells against the reactive oxygen free radicals, and inhibits osteoclastic function.
There also exist information on genotoxicity of genistein detected by studies in vivo and in vitro using higher concentrations (for review see STOPPER et al. 2005) .
MESSINA and LOPRINZI (2001), while reviewing the literary data, came to uncertainity that the comsumption of soya may affect the risk of breast cancer or the survival of breast cancer patiens. Because of this conflicting results, genistein is under intensive study.
In our work, we present the effect of genistein on the mutagenicity of two indirect mutagens, i.e. aflatoxin B 1 (AFB 1 ) and 2-amino-3-methylimidazo [4,5-f ]quinoline (IQ), and on the mutagenicity of the direct mutagen N-nitroso-N-methylurea (MNU), using the Ames test in vitro, and the micronucleus test in vivo.
MATERIAL AND METHODS

The Ames test
For the evaluation of the antimutagenic effect of genistein in vitro, the Ames test was performed using Salmonella typhimurium TA98 and TA100 strains (AMES 1971; AMES et al. 1975; MARON & AMES 1983; ČERNÁ et al. 1989) .
The mutagenic substances were used at the following concentrations: AFB 1 at the concentrations of 10 µg, 1 µg, and 0.1 µg per plate in both strains, TA98 and TA100; IQ at the concentrations of 0.1 µg, 0.01 µg, and 0.001 µg per plate in the strain TA98, and at the concentrations of 10 µg, 1 µg, and 0.1 µg in the strain TA100; MNU at the concentrations of 1000 µg, 100 µg, and 10 µg in the strain TA100 only. These MNU concentrations had no effect upon the strain TA98. Each concentration of the individual mutagens was combined with four different concentrations of genistein (300 µg, 30 µg, 3 µg, and 0.3 µg per plate). All chemicals were diluted in DMSO. For the metabolic activation the S9 liver homogenate fraction from laboratory rats treated with a mixture of polychlorinated biphenyls Delor was used (MARON & AMES 1983) . All combinations of the mutagens and antimutagen were tested in two separate experiments, with three plates in each experiment.
The percentage of the inhibition of mutagenicity was calculated using the following formula: 
The micronucleus test
The experiments in vivo (bone marrow micronucleus test) were carried out on ten-week-old male Balb C mice, weighing 22-26 g. The animals were housed under standard conditions in groups of 10 mice for the treatment.
The following concentrations of mutagens were used for in vivo tests: AFB 1 5 mg/kg of body weight (b.w.), IQ 20 mg/kg b.w., MNU 50 mg/kg b.w.
Genistein was administered at the dose of 20 mg per kg b.w. to mice by gavage for three consecutive days. Carcinogens were administered at one dose on the third day. All the substances (diluted in DMSO) were administered in the volumes of 100 µl/10 g b.w. The control mice were orally treated with 7% solution of DMSO.
The mouse bone marrow micronucleus test was carried out according to SCHMID (1975) . A total of 1000 polychromatophilic erythrocytes were scored per animal by the same observer for evaluating the frequencies of micronucleated polychromatophilic erythrocytes. Each experiment was run three times.
The statistical significance of the differences between two means defined for the respective mutagen and its mixture with genistein was tested by the Student's t-test.
RESULTS
The results of the Ames test (Tables 1-3) are expressed as a number of revertants, and also as the percentage of inhibition of the mutagen activity of the sample consisting of a mixture of the respective mutagen and genistein in comparison with the mutagenicity of the individual mutagen, according to the formula presented in Methods.
The number of revertants induced by genistein did not differ from the control values. Two highest concentrations of genistein (300 and 30 µg per plate) revealed a significant dose -dependent antimutagenic effect upon all concentrations of AFB 1 in the TA98 and TA100 strains. The lower concentration of genistein, 3 µg per plate, was significantly antimutagenic only in combination with 1 and 0.1 µg of AFB 1 per plate in both strains (Table 1) . The effect of genistein on IQ mutagenicity was more pronounced in the tests with TA98 strain than in those with TA100 strain. Two highest genistein concentrations were antimutagenic in combinations with all doses of IQ in TA98, while the concentration of 3 µg per plate only in combination with the lowest IQ dose (0.001 µg per plate). The effect was dose dependent. However, in the strain TA100 only the highest concentration (300 µg per plate) significantly suppressed the mutagenicity of 10 and 1 µg of IQ per plate ( Table 2) .
The mutagenicity of the direct mutagen MNU was suppressed by 300 µg of genistein per plate in combinations with 100 and 10 µg of MNU per plate in the strain TA100. Other concentrations of genistein were without the antimutagenic effect (Table 3 ).
In the micronucleus tests all three mutagens revealed significant mutagenic activities. The number of micronuclei in animals influenced by genistein alone did not differ from that of the control group. Oral administration of the combination of genistein (at a dose of 20 mg/kg b.w.) and aflatoxin B 1 revealed a lower number of micronuclei in polychromatophilic erythrocytes in a statistically significant degree in comparison with laboratory mice treated with AFB 1 alone.
Similarly, a significant suppression of IQ mutagenicity was reached with the combination of genistein and the IQ mutagen.
The treatment of mice with the combination of genistein and MNU resulted in a significant reduction of the number of micronuclei in comparison with the number of micronuclei induced Table 4 .
DISCUSSION
It is well known that damage to the genome or aberrant DNA methylation, resulting in aberrant gene expression (suppression of tumour suppressor genes and inappropriate expression of oncogenes), is fundamental to tumorigenesis. The variability in cancer expression is due to the differences in the amount of DNA damage and the capacity to repair DNA damage, both being influenced by the genetic predisposition (gene polymorphism) and the dietary factors. Metabolism including the detoxification of genotoxic chemicals is influenced by the dietary factors, and the dietary intervention offers us a good oportunity for the cancer prevention.
Many protective compounds were discovered in plants; among them, genistein has been extensively investigated for its chemopreventive ability, especially against tumours of breast and prostate. Its effect involves antioxidant properties, modulation of key enzymes and inhibitors of the cell cycle (CHOI et al. 1998a, b) , and induction of apoptosis in transformed cells (KUMI-KIAKA et al. 2000; SARKAR & LI 2004) .
On the other hand, there are also studies on genotoxicity of this compound. In experimental animals, DINGLEY et al. (2003) detected an increase of PhIP (2-amino-1-methyl-6 phenyl-imidazo[4,5-b] pyridine) adducts but not IQ adducts after genistein treatment. In the study by TSUTSUI et al. (2003) genistein was shown to induce chromosomal aberrations, aneuploidies, DNA adducts, and transformation of Syrian hamster embryonal cells. MISRA et al. (2002) described a significant increase in the frequency of micronucleated erythrocytes, but this effect was small and not dose related; genistein had no effect on the incidence of tumours developed in p53 knockout mice. Misra did not prove the genotoxic effect in the Ames test without metabolic activation; after metabolic SD -standard deviation; *P < 0.05; **P < 0.01 *significantly higher number of micronuclei as against the negative control (DMSO) **significantly lower number of micronuclei as against mutagen alone SD -standard deviation activation, only a small increase in the number of revertants was detected in TA100 strain of Salmonella typhimurium, however, not in other tester strains. We did not detect any genotoxic effect of genistein either in the Ames test or in the micronucleus test, because the number of revertants or the number of micronuclei did not differ significantly from the controls. We proved a clear dose-dependent antimutagenic effect of genistein upon the indirect mutagenicity of AFB 1 and IQ in the Ames test. The effect upon AFB 1 mutagenicity was similar in TA98 and TA100 strains. The effect upon IQ mutagenicity was stronger in TA98 strain than in TA100 strain. The direct mutagenicity of MNU was suppressed only by the highest concentration of genistein in TA100 strain. Clear antimutagenic effects of genistein upon the mutagenicity of all three mutagens were also proved in the micronucleus test.
Similar results were achieved by WEISBURGER et al. (1998) in the Ames test, a dose-related inhibition of the mutagenicity of heterocyclic amine PhIP by genistein was detected. MIYAZAVA et al. (1999) proved antimutagenic activity of genistein against Trp-P-1 (3-amino-1,4-dimethyl-5H-pyrido [4,3-b] indole) and furylfuramide in the Ames and umu tests.
Antigenotoxic effect of genistein and also its opposite effect are discussed in excellent reviews by POLKOWSKI and MAZUREK (2000) , LI (2002) and SURH (2004) , altogether with the explanation of its effects at molecular and cellular levels.
It is supposed that genotoxicity of genistein can be caused by the inhibition of DNA topoisomerase II resulting in stabilisation of DNA double strand breaks at topoisomerase II-DNA binding sites (BOOS & STOPPER 2000; SNYDER & GILLIES 2002; STOPPER et al. 2005) .
It is evident that the understanding of the effects of genistein and other phytoestrogens is far from being clear. Their bipolar response -protective in lower doses and possible genotoxicity of higher doses, especially in in vivo experiments, needs additional studies in this field. It is also obvious that the concentrations necessary for the genotoxic effect in in vitro studies and in experimental studies in vivo can hardly be reached by our usual diet. But we must be carefull with the use of phytoestrogen concentrates in menopause. Phytoestrogens are often presented as non-hormonal. This may be dangerous for the women under the risk of re-occurrence of estrogen dependent cancers. In addition, the review of 105 clinical studies has not brought any clear proof that phytoestrogens lower the risk of breast cancer and cardiovascular diseases, but it seems to be evident that they decrease the risk of osteoporosis (CORNWELL et al. 2004) .
Since phytoestrogen genistein has a lower afinity to the estrogen receptors than the physiological ligand estradiol, it may act as an enhancer of the cell proliferation in the absence of hormone, but may be anti-estrogenic in the presence of estradiol and reduce estradiol-mediated cell proliferation. Interactions of different compounds with genotoxic and antigenotoxic effects may change the final effect of the individual compounds. Additionally, other environmental or life style factors may be related to the risk of cancers (BOUKER & HILAKIVI-CLARKE 2000) .
The reviewed data indicate that the intake of concentrated phytoestrogens as supplements should not be advised to menopausal women while diet containing high amounts of plant substances is important for the health maintenance (STOPPER et al. 2005) .
Further studies are needed on the effects of genistein and other phytoestrogens, especially studies on the combined effects of different plant substances, because of the possible interactions of genotoxic and antigenotoxic compounds. In a diet, this interactions may result in potentiation, as well as in antagonistic effects.
